UNIGE document Scientific Article
previous document  unige:9067  next document
add to browser collection

Amiloride selectively inhibits the urokinase-type plasminogen activator

Published in FEBS letters. 1987, vol. 214, no. 1, p. 187-191
Abstract The diuretic drug amiloride, an inhibitor of Na+ uptake, competitively inhibits the catalytic activity of the urokinase-type plasminogen activator (u-PA), with a Ki of 7 X 10(-6) M. Generation of plasmin, cleavage of peptide substrates, and interaction of u-PA with a specific macromolecular proteinase inhibitor are all prevented in the presence of the drug. In contrast, amiloride does not affect the activity of either tissue-type plasminogen activator, plasmin, plasma kallikrein or thrombin. The inhibition of u-PA by amiloride may be related to the previously reported inhibition of u-PA-type enzymes by Na+. Amiloride or related compounds could prove useful in selectively controlling u-PA-catalyzed extracellular proteolysis.
Keywords Amiloride/ pharmacologyAnimalsHumansKineticsPlasminogen Activators/ antagonists & inhibitorsPlasminogen InactivatorsProtease Inhibitors/metabolismSodium/metabolismTissue Plasminogen Activator/antagonists & inhibitorsUrokinase-Type Plasminogen Activator/ antagonists & inhibitors
PMID: 3106085
Full text
Article - document accessible for UNIGE members only Limited access to UNIGE
(ISO format)
VASSALLI, Jean-Dominique, BELIN, Dominique. Amiloride selectively inhibits the urokinase-type plasminogen activator. In: FEBS letters, 1987, vol. 214, n° 1, p. 187-191. doi: 10.1016/0014-5793(87)80039-x https://archive-ouverte.unige.ch/unige:9067

469 hits

0 download


Deposited on : 2010-07-12

Export document
Format :
Citation style :